These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7912614)

  • 21. Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell.
    King D; Zigmond MJ; Finlay JM
    Neuroscience; 1997 Mar; 77(1):141-53. PubMed ID: 9044382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between the noradrenergic and serotonergic systems in locomotor hyperactivity and striatal expression of Fos induced by amphetamine in rats.
    Muñoz A; Lopez-Real A; Labandeira-Garcia JL; Guerra MJ
    Exp Brain Res; 2003 Nov; 153(1):92-9. PubMed ID: 12955385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disruption of dopaminergic neurotransmission in nucleus accumbens core inhibits the locomotor stimulant effects of nicotine and D-amphetamine in rats.
    Boye SM; Grant RJ; Clarke PB
    Neuropharmacology; 2001 May; 40(6):792-805. PubMed ID: 11369033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Locomotor activity and accumbens Fos expression driven by ventral hippocampal stimulation require D1 and D2 receptors.
    Bardgett ME; Henry JD
    Neuroscience; 1999; 94(1):59-70. PubMed ID: 10613497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paradoxical constitutive behavioral sensitization to amphetamine in mice lacking 5-HT2A receptors.
    Salomon L; Lanteri C; Godeheu G; Blanc G; Gingrich J; Tassin JP
    Psychopharmacology (Berl); 2007 Sep; 194(1):11-20. PubMed ID: 17510759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens.
    Mathé JM; Nomikos GG; Hildebrand BE; Hertel P; Svensson TH
    Eur J Pharmacol; 1996 Aug; 309(1):1-11. PubMed ID: 8864686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeated ventral midbrain neurotensin injections sensitize to amphetamine-induced locomotion and ERK activation: A role for NMDA receptors.
    Voyer D; Lévesque D; Rompré PP
    Neuropharmacology; 2017 Jan; 112(Pt A):150-163. PubMed ID: 27267684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ventral striatal noradrenergic mechanisms contribute to sensorimotor gating deficits induced by amphetamine.
    Alsene KM; Fallace K; Bakshi VP
    Neuropsychopharmacology; 2010 Nov; 35(12):2346-56. PubMed ID: 20686455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of locomotor sensitization by amphetamine requires the activation of NMDA receptors in the rat ventral tegmental area.
    Vezina P; Queen AL
    Psychopharmacology (Berl); 2000 Aug; 151(2-3):184-91. PubMed ID: 10972464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of intra-tegmental microinjections of 5-HT1B receptor ligands on the amphetamine-induced locomotor hyperactivity in rats.
    Papla I; Filip M; Przegaliński E
    Pol J Pharmacol; 2002; 54(4):351-7. PubMed ID: 12523488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of D1 dopamine receptors in the medial prefrontal cortex attenuates amphetamine- and methamphetamine-induced locomotor activity in the rat.
    Hall DA; Powers JP; Gulley JM
    Brain Res; 2009 Dec; 1300():51-7. PubMed ID: 19733155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine.
    Cador M; Bjijou Y; Stinus L
    Neuroscience; 1995 Mar; 65(2):385-95. PubMed ID: 7777156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine-dependent hyperactivity in the rat following manipulation of GABA mechanisms in the region of the nucleus accumbens.
    Pycock CJ; Horton RW
    J Neural Transm; 1979; 45(1):17-33. PubMed ID: 112217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D-amphetamine-induced behavioral sensitization: effect of lesioning dopaminergic terminals in the medial prefrontal cortex, the amygdala and the entorhinal cortex.
    Bjijou Y; De Deurwaerdere P; Spampinato U; Stinus L; Cador M
    Neuroscience; 2002; 109(3):499-516. PubMed ID: 11823062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Locomotor hyperactivity induced by blockade of prefrontal cortical alpha2-adrenoceptors in monkeys.
    Ma CL; Arnsten AF; Li BM
    Biol Psychiatry; 2005 Jan; 57(2):192-5. PubMed ID: 15652880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Septal lesions enhance hyperactivity induced either by amphetamine or lesions of the nucleus accumbens septi.
    Carey RJ
    Behav Brain Res; 1982 May; 5(1):43-52. PubMed ID: 7082466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-D-aspartate antagonists.
    Wolf ME; Dahlin SL; Hu XT; Xue CJ; White K
    Neuroscience; 1995 Nov; 69(2):417-39. PubMed ID: 8552239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amphetamine promotes cortical Up state: Role of adrenergic receptors.
    Shen G; Shi WX
    Addict Biol; 2021 Jan; 26(1):e12879. PubMed ID: 32003119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of the locomotor response to amphetamine by corticosterone.
    Cador M; Dulluc J; Mormède P
    Neuroscience; 1993 Oct; 56(4):981-8. PubMed ID: 8284048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.